The global anticoccidial drugs market was valued at $171.3 million in 2021, and is projected to reach $257.8 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031.
Report Code : A14844 | Pages : 220 | Category : Life Sciences
The global antibody discovery market was valued at $6.9 billion in 2022, and is projected to reach $17.2 billion by 2032, growing at a CAGR of 9.6% from 2023 to 2032.
Report Code : A14913 | Pages : 252 | Category : Life Sciences
The global injectable cement market was valued at $1.3 billion in 2021, and is projected to reach $2.3 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031.
Report Code : A14916 | Pages : 226 | Category : Life Sciences
The global iodine deficiency drug market was valued at $3.7 billion in 2021, and is projected to reach $6.5 billion by 2031, growing at a CAGR of 5.8% from 2022 to 2031.
Report Code : A14921 | Pages : 199 | Category : Life Sciences
The global radiopharmaceuticals market was valued at $8 billion in 2023, and is projected to reach $21.8 billion by 2033, growing at a CAGR of 10.6% from 2024 to 2033.
Report Code : A14458 | Pages : 500 | Category : Life Sciences
The India, Bangladesh, Sri Lanka, Nepal Animal Vaccine market was valued at $127,107.12 thousand in 2020, and is estimated to reach $229,987.00 thousand by 2030, growing at a CAGR of 6.1% from 2021 to 2030.
Report Code : A14825 | Pages : 152 | Category : Life Sciences
The India, Bangladesh, Sri Lanka, Nepal pet parasiticides market size was valued at $14,772.23 thousand in 2020, and is projected to reach $23,944.89 thousand by 2030, registering a ...
Report Code : A14890 | Pages : 146 | Category : Life Sciences
The global rabeprazole sodium market was valued at $615.7 million in 2021, and is projected to reach $895.9 million by 2031, growing at a CAGR of 3.8% from 2022 to 2031.
Report Code : A15375 | Pages : 191 | Category : Life Sciences
The global myelofibrosis treatment market was valued at $786.1 million in 2021, and is projected to reach $1,160.29 million by 2031, growing at a CAGR of 4% from 2022 to 2031.
Report Code : A15378 | Pages : 181 | Category : Life Sciences
The global mumps vaccine market was valued at $2 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 5.8% from 2022 to 2031.
Report Code : A15401 | Pages : 146 | Category : Life Sciences
The global pharmaceutical primary packaging label market size was valued at $2,377.83 million in 2020, and is projected to reach $4,762.81 million by 2030 registering a CAGR of ...
Report Code : A15417 | Pages : 277 | Category : Life Sciences
The global thalassemia market was valued at $2,580.64 million in 2021, and is projected to reach $4,205.95 million by 2031, growing at a CAGR of 5% from 2022 to 2031.
Report Code : A15443 | Pages : 215 | Category : Life Sciences
The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031.
Report Code : A15445 | Pages : 148 | Category : Life Sciences
The global pancrelipase market was valued at $1.8 billion in 2021, and is projected to reach $2.7 billion by 2031, growing at a CAGR of 4.3% from 2022 to 2031.
Report Code : A15450 | Pages : 157 | Category : Life Sciences
The global menstrual cramps treatment market was valued at $560.9 million in 2021, and is projected to reach $841.6 million by 2031, growing at a CAGR of 4.1% from 2022 to 2031.
Report Code : A15451 | Pages : 207 | Category : Life Sciences
The global olanzapine market was valued at $1.8 billion in 2021, and is projected to reach $2.2 billion by 2031, growing at a CAGR of 2.3% from 2022 to 2031.
Report Code : A15452 | Pages : 229 | Category : Life Sciences
The global wilson disease drugs market was valued at $595.2 million in 2021, and is projected to reach $848.2 million by 2031, growing at a CAGR of 3.6% from 2022 to 2031.
Report Code : A15455 | Pages : 211 | Category : Life Sciences
The global blastomycosis market was valued at $177.2 million in 2021, and is projected to reach $257.7 million by 2031, growing at a CAGR of 3.8% from 2022 to 2031.
Report Code : A15629 | Pages : 240 | Category : Life Sciences
The global Duchenne muscular dystrophy market size was valued at $1,301.44 Million in 2021, and is estimated to reach $2,073.91 Million by 2031, growing at a CAGR of 4.7% from 2022 to 2031.
Report Code : A15646 | Pages : 143 | Category : Life Sciences
The global toxoplasmosis treatment market was valued at $683.1 million in 2021, and is projected to reach $1,093.88 million by 2031, growing at a CAGR of 4.8% from 2022 to 2031.
Report Code : A15647 | Pages : 210 | Category : Life Sciences
The Pharmaceutical Glycerin Based Products Market was valued at $34.6 billion in 2020 and is projected to reach $61.6 billion by 2030, growing at a CAGR of 5.9% from 2021 to 2030.
Report Code : A15924 | Pages : 196 | Category : Life Sciences
The global softgel capsule market was valued at $4.4 billion in 2021, and is projected to reach $7.5 billion by 2031, growing at a CAGR of 5.4% from 2022 to 2031.
Report Code : A16306 | Pages : 265 | Category : Life Sciences
CAR T-cell therapy market size was valued at $2.6 billion in 2022 and is estimated to reach $35.9 billion by 2032, exhibiting a CAGR of 28.5% from 2023 to 2032.
Report Code : A16971 | Pages : 219 | Category : Life Sciences
The global house dust mite allergy treatment market was valued at $1.5 billion in 2021, and is projected to reach $5.2 billion by 2031, growing at a CAGR of 13.4% from 2022 to 2031.
Report Code : A16570 | Pages : 245 | Category : Life Sciences
South Africa Diabetic nephropathy Market size is projected to increase at a lucrative rate during the forecast period. The South Africa Diabetic nephropathy Market report covers the drivers, ...
Report Code : A16604 | Pages : 266 | Category : Life Sciences
